Hypoxia: Clinical Trials

12 trials for Hypoxia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 unknown. 12 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 112Unknown 12
Phase 24Unknown 4

Follow Hypoxia: new trials by email Literature Review of Hypoxia trials Research Report on Hypoxia

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reducing Hypoxia in Patients With Coronavirus Disease (COVID-19) Using Topotecan With Standard of Care
Topotecan - COVID-19 Respiratory Infection
Phase 1UnknownNational University Hospital, Singapore242021-08-162021-11-04
Tolerability and Efficacy of RJX in Patients With COVID-19
Rejuveinix (RJX) Active Comparator, Placebo Comparator - COVID-19, Acute Respiratory Distress Syndrome
Phase 1 / Phase 2UnknownReven Pharmaceuticals, Inc.2372021-03-252022-03-15
Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia
autologous umbilical cord blood (UCB), standard care - Hypoxic-Ischemic Encephalopathy, Hypoxia Neonatal
Phase 1UnknownMononuclear Therapeutics Ltd.402018-04-162018-06-07
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Evofosfamide, Ipilimumab - Pancreatic Cancer, Melanoma
Phase 1UnknownThreshold Pharmaceuticals692017-05-102017-10-30
The Haem and Nitrite Study - The Effects of Haemoglobin NO-blockade on Nitrite-induced Forearm Vessel Dilatation
Sodium Nitrite - Healthy Volunteers
Phase 1UnknownUniversity of East Anglia412016-12-012017-03-20
Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm
OXY111A - Pancreatic Neoplasms, Hepatocellular Cancer
Phase 1 / Phase 2UnknownUniversity of Zurich692014-02-012015-08-19
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Hypoxic Ischemic Encephalopathy
mesenchymal stem cells - Hypoxic Ischemic Encephalopathy
Phase 1UnknownHebei Medical University102013-09-012013-10-14
Vasopressors for Cerebral Oxygenation
dopamine, phenylephrine - Hypoxia, Hypotension
Phase 1UnknownSamsung Medical Center502012-12-012013-12-11
Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury
Sodium Nitroprusside - Acute Lung Injury, Acute Respiratory Distress Syndrome
Phase 1UnknownMount Sinai Hospital, Canada302012-05-012012-06-14
Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma
TH-302, TH-302 and Dexamethasone, TH-302 Dose Escalation and Dexamethasone in Combination with Bortezomib - Multiple Myeloma
Phase 1 / Phase 2UnknownThreshold Pharmaceuticals982012-02-012016-06-02
Whole Body Cooling Using Phase Changing Material
Cooling - Hypoxic Ischemic Encephalopathy
Phase 1 / Phase 2UnknownRobertson, Nicola, M.D.352009-07-012010-06-07
Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
AQ4N - Solid Malignancies, Non-Hodgkin's Lymphoma
Phase 1UnknownNovacea452004-08-012006-11-02

Narrower conditions

Hypoxia-Ischemia, Brain (3)  ·  Pancreatic Neoplasms (3)  ·  Colorectal Neoplasms (2)  ·  Prostatic Neoplasms (2)  ·  Respiratory Distress Syndrome (2)  ·  Acute Lung Injury (1)  ·  Anemia, Neonatal (1)  ·  Aneurysm (1)  ·  Asphyxia Neonatorum (1)  ·  Breast Neoplasms (1)  ·  COVID-19 (1)  ·  Cholangiocarcinoma (1)  ·  Head and Neck Neoplasms (1)  ·  Hypotension (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (12)  ·  Signs and Symptoms (12)  ·  Signs and Symptoms, Respiratory (12)  ·  Cardiovascular Diseases (6)  ·  Vascular Diseases (6)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Brain Diseases (3)  ·  Brain Ischemia (3)  ·  Central Nervous System Diseases (3)  ·  Cerebrovascular Disorders (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)

Interventions

TH 302 (2)  ·  AQ4N (1)  ·  Bortezomib (1)  ·  Cool-Down Exercise (1)  ·  Dexamethasone (1)  ·  Dopamine (1)  ·  Hypothermia, Induced (1)  ·  Injections (1)  ·  Ipilimumab (1)  ·  Nitroprusside (1)  ·  Phenylephrine (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Sodium Nitrite (1)  ·  Standard of Care (1)

Sponsors

Threshold Pharmaceuticals (2)  ·  Hebei Medical University (1)  ·  Mononuclear Therapeutics Ltd. (1)  ·  Mount Sinai Hospital, Canada (1)  ·  National University Hospital, Singapore (1)  ·  Novacea (1)  ·  Reven Pharmaceuticals, Inc. (1)  ·  Robertson, Nicola, M.D. (1)  ·  Samsung Medical Center (1)  ·  University of East Anglia (1)  ·  University of Zurich (1)

Countries

United States (4)  ·  India (2)  ·  Canada (1)  ·  China (1)  ·  Hong Kong (1)  ·  South Korea (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Balraj Guhan, MD (1)  ·  Baoyong Yan, Doctor (1)  ·  David Hong, MD (1)  ·  Hyun Joo Ahn (1)  ·  Jun Zhang, Master (1)  ·  Lina Zhang, Master (1)  ·  Michael P Frenneaux, FRCP, FESC (1)  ·  Pierre Alain, Clavien (1)  ·  Ping Gu, Doctor (1)  ·  Sangeeta Mehta, MD FRCPC (1)  ·  Simon Lam, MD (1)  ·  Terence Ip, MD (1)  ·  Yanyong Wang, Doctor (1)

Results publications

PMID 27756258, PMID 34155211